AnovoRx was created in 2012 by executives with significant experience in the specialty pharmacy and biopharmaceutical industry
Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs
According to BioCryst Pharmaceuticals, the maker of Orladeyo, the medicine will be provided exclusively by specialty pharmacy Optime Care
Amplity Health offers commercial execution expertise and resources for sales force, remote engagement, training, market access and select operations services
PharMerica is a leading provider of home and community-based health and pharmacy services for high-need and medically complex populations
Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics
AnovoRx’s focus is intentionally centered on the unique needs of patients with chronic diseases who rely on specialty and orphan drugs as well as manufacturers
Biophama companies are increasingly interested in establishing relationships with experienced specialty pharmacies to dispense rare disease drugs to patients